Phreesia (PHR) | Stock Overview & Key Data
Phreesia Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $81.59 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2026
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Phreesia
PHR
|
568.74M Small-cap | 5.70% | -0.21% | -21.99% | -52.65% | -40.80% | -59.74% | -69.80% | -81.61% | -58.92% | -58.92% | -58.92% |
|
Ge Healthcare
GEHC
|
31.89B Large-cap | -2.90% | 1.69% | -20.61% | -25.79% | -25.10% | -11.62% | -22.05% | 9.87% | 9.87% | 9.87% | 9.87% |
|
Veeva Systems
VEEV
|
26.49B Large-cap | 12.76% | 4.99% | -3.87% | -25.94% | -18.57% | -37.67% | -10.59% | -39.53% | 399.40% | 292.75% | 292.75% |
|
Omnicell
OMCL
|
1.65B Small-cap | -2.85% | -3.57% | 2.67% | 3.48% | -7.20% | 45.34% | -40.34% | -68.37% | 35.61% | 212.38% | 209.75% |
|
Teladoc Health
TDOC
|
1.04B Small-cap | 7.59% | 6.94% | 39.02% | -5.84% | 0.57% | 9.97% | -68.91% | -94.81% | -35.62% | -72.82% | -72.82% |
|
Certara
CERT
|
969.01M Small-cap | 4.67% | -9.53% | -22.65% | -42.15% | -35.93% | -48.77% | -73.18% | -77.81% | -84.72% | -84.72% | -84.72% |
Ownership & Short Interest
Calculate Your Phreesia Investment Returns
Long-Term Investment Performance Analysis
Phreesia stock price in Jul 2019 was $24.00, A $1,000.00 lump sum investment in Phreesia made 6 years ago would be worth approximately $402.08 today, representing a negative return of -59.79%. This translates to an annualized return (CAGR) of -12.39%.
6 Years 10 Months Investment Scenario (Jul 2019 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PHR's 52-week high and low?
- In the last 52 weeks, Phreesia reached a high of $32.76 (on August 28, 2025) and a low of $7.77 (on March 31, 2026).
- What is the market cap and P/E ratio for PHR?
- Curious about Phreesia's size and valuation? Its market capitalization stands at 568.74M. When it comes to valuation, the P/E ratio (trailing twelve months) is 229.25, and the forward P/E (looking ahead) is 5.42.
- Does PHR pay dividends? If so, what's the yield?
- As for dividends, Phreesia isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Phreesia's main competitors or similar companies to consider before investing?
When looking at Phreesia, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ge Healthcare
GEHC31.89B Healthcare Health Information Services -11.62% -22.05% Veeva Systems
VEEV26.49B Healthcare Health Information Services -37.67% -10.59% Omnicell
OMCL1.65B Healthcare Health Information Services 45.34% -40.34% Teladoc Health
TDOC1.04B Healthcare Health Information Services 9.97% -68.91% Certara
CERT969.01M Healthcare Health Information Services -48.77% -73.18% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Phreesia Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Phreesia's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.77%, the Debt to Equity ratio from the most recent quarter is 30.38, and its Gross Profit Margin stands at 68.21%.
- What is the recent revenue and earnings growth for PHR?
- Looking at Phreesia's growth, its revenue over the trailing twelve months (TTM) was $481M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.90%, and quarterly earnings saw a YoY growth of 15.85%.
- How much of PHR stock is held by insiders and institutions?
- Wondering who owns Phreesia stock? Company insiders (like executives and directors) hold about 4.72% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 114.71%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.